Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SOS2 |
| Upstream (Parents) |
|---|
| (<<) ACTB → SOS2 |
| (<<) ADAM9 → SOS2 |
| (<<) ATF2 → SOS2 |
| (<<) B3GNT2 → SOS2 |
| (<<) CREB1 → SOS2 |
| (<<) DAZAP2 → SOS2 |
| (<<) HIPK1 → SOS2 |
| (<<) ITGB1 → SOS2 |
| (<<) KCTD5 → SOS2 |
| (<<) MAP3K2 → SOS2 |
| (<<) PRPF4B → SOS2 |
| (<<) PTPN11 → SOS2 |
| (<<) PTPN12 → SOS2 |
| (<<) RAB5A → SOS2 |
| (<<) RHOA → SOS2 |
| (<<) RXRB → SOS2 |
| (<<) RYK → SOS2 |
| (<<) SHC1 → SOS2 |
| (<<) YWHAZ → SOS2 |
| Downstream (Children) |
|---|
| SOS2 → ADAM17 (>>) |
| SOS2 → CABC1 (>>) |
| SOS2 → CALM3 (>>) |
| SOS2 → CASP8 (>>) |
| SOS2 → CDK8 (>>) |
| SOS2 → CSNK1A1 (>>) |
| SOS2 → HMGCS1 (>>) |
| SOS2 → MERTK (>>) |
| SOS2 → NUPR1 (>>) |
| SOS2 → OBSCN (>>) |
| SOS2 → PYGL (>>) |
| SOS2 → RNASE4 (>>) |
| SOS2 → SULF2 (>>) |
| SOS2 → TIMP3 (>>) |
| SOS2 → TP53 (>>) |
| SOS2 → TXNIP (>>) |
| SOS2 → VAV3 (>>) |
| SOS2 → YRDC (>>) |
| SOS2 → ZFP36L1 (>>) |
